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EDITORIAL COMMENT
Dietary Research in Heart Failure
Beyond the Salt Shaker*
Marc A. Silver, MD, FACC
Oak Lawn, Illinois
Anyone caring for patients with heart failure (HF) is aware
of the importance of dietary instruction for these patients.
Because of the patients’ salt-avid state, these instructions
generally follow the admonition for a reduction of sodium
intake. In a related fashion, particularly for patients with
evidence of volume overload and diuretic therapy require-
ments, fluid restriction is the next most common instruction.
Finally, often related to an atherogenic substrate, dietary
restriction of saturated fats is commonly the third admonition.
In general, aside from the dietary restrictions related to a
patient’s evidence of edema or the diagnosis of coronary artery
disease or hyperlipidemia, little attention has been paid to
dietary assessment, evaluation, instruction, or research for the
vast majority of HF patients. This is, indeed, unfortunate
because there are suggestions that as many as 50% of patients
hospitalized with HF are malnourished (1).
See page 1218
Heart failure textbooks and guidelines add little addi-
tional information or suggestion of the magnitude of the
need for information regarding nutritional assessment of
patients with HF (2–4). A single text contains one page out
of 929 focusing only on cachexia (2). And among the
paucity of data exists the widest spectrum of opinion. A
recent Framingham analysis related increased body mass
index (BMI) with worsened survival (5). Conversely, other
studies have suggested that survival may in fact be better
with higher BMIs or, in fact, with obesity (6,7).
Were a student or resident to ask me about information
on the general nutritional status of patients with HF, my
response would suggest that weight loss in advanced disease
due to malabsorption and wastage of nutrients coupled with
a decrease in appetite seen in the volume overloaded patient
is common. I would also mumble something about the need
to attain ideal body weight. But the response would lack
critical data, conviction, or, more importantly, suggestions
aimed at proper nutritional replacement and support.
Therefore, I welcome the paper by Aquilani et al. (8) in
this issue of the Journal. In the background information for
this study the authors rightfully explain, “little information
exists regarding the nutritional adequacy and alimentary
habits of patients with clinically stable chronic HF.” The
authors looked beyond simple morphometrics and per-
formed a prospective analysis of nutritional balance. The
authors studied carefully 57 non-obese, community-living
patients mostly with mild to moderate HF. The population
is not perfect for broader extrapolation; the patients were
briefly hospitalized for transplant evaluation, and, despite
their moderate functional class, many had exceedingly low
peak oxygen uptake. Nonetheless, the only neurohormone
measured was plasma norepinephrine and these levels were
only modestly elevated. Importantly, the authors excluded
patients taking beta-blockers, concerned that metabolic rate
might be affected. The population therefore might best be
described as having Stage C (4) disease on suboptimal
therapy—akin to many general HF populations! Age-,
BMI-, and activity-matched subjects served as a suitable
control group.
More important, however, is the author’s study of the
calorie-nutrition balance (CNB), which reflects a daily
homeostasis between calorie-nitrogen intake over excretion
and its relationship to total energy expenditure. The meth-
ods seem adequate, although one might debate how resting
energy expenditure (REE) is measured or calorie/nitrogen
intake (based on seven-day food diaries) assessed; again not
an important point to belabor.
The authors demonstrate a remarkable proportion of
patients having a negative calorie balance (70.1%), negative
nitrogen balance (59.6%), or negative combined CNB
(40.3%). This occurred despite similar calorie and nitrogen
intake, not only in HF patients but also in controls; only
underweight controls took in fewer calories. The next impor-
tant finding is that total energy expenditure was the same in
HF patients and controls. Doing the math, one then readily
understands the authors’ conclusions—these patients simply do
not have enough energy available for physical expenditure on
activity, let alone stresses related to periods of decompensation,
infection, or enhanced physical training.
The authors’ work, however, (and that of the HF com-
munity) remains undone. No new information is offered as
to how or why the nutritional balance is so poor in these
patients. Presumed is a progressive change in dietary habits
coupled with chronic malabsorption of macro and micro-
nutrients. Much could be learned by studying CNB in
patients earlier along the HF path (Stages A and B).
Whether cytokine activity, drug effects on taste, or even
subclinical depression alters intake is not well known. Also,
we do not know what forces may be at play to keep the
energy expenditure of the “sedentary” HF patient so high.
We also do not know what role the negative balance plays in
the symptoms of the HF syndrome nor on its progression.
And finally, we do not know the impact of prescribed
weight loss or exercise training on these patients.
What we do now know is that our patients are likely
starving before us, and we may be inadvertently making it
worse. Unfortunately, calculating CNB is not a simple
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bedside procedure. Also, nutrition in HF patients is not
likely to either share the exciting spotlight of new drug or
device development in HF or have similar access to funding
resources. Yet, many questions remain—questions that may
play an important role in limiting our HF epidemic. We
should applaud the authors on this novel approach. I also
encourage young investigators, and all of us, to begin to
think “beyond the salt shaker.”
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